BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31499255)

  • 1. Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy.
    Sun Q; Bi H; Wang Z; Li C; Wang X; Xu J; Zhu H; Zhao R; He F; Gai S; Yang P
    Biomaterials; 2019 Dec; 223():119473. PubMed ID: 31499255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.
    Xia J; Du Y; Huang L; Chaurasiya B; Tu J; Webster TJ; Sun C
    Nanomedicine; 2018 Apr; 14(3):713-723. PubMed ID: 29317344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Cell-Targeted Photosensitizer and Therapeutic Protein Co-Delivery Nanoplatform Based on a Metal-Organic Framework for Enhanced Synergistic Photodynamic and Protein Therapy.
    Ding L; Lin X; Lin Z; Wu Y; Liu X; Liu J; Wu M; Zhang X; Zeng Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(33):36906-36916. PubMed ID: 32706242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin.
    Li M; Yue X; Wang Y; Zhang J; Kan L; Jing Z
    J Mater Chem B; 2019 Dec; 7(47):7619-7626. PubMed ID: 31746936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
    Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
    Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Responsive hyaluronic acid-enveloped ZIF-8 nanoparticles for anti-atherosclerosis therapy.
    Obaid EAMS; Wu S; Zhong Y; Yan M; Zhu L; Li B; Wang Y; Wu W; Wang G
    Biomater Sci; 2022 Aug; 10(17):4837-4847. PubMed ID: 35858474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable Imprinted Polymer Based on ZIF-8/DOX-HA for Synergistically Targeting Prostate Cancer Cells and Controlled Drug Release with Multiple Responses.
    Song Y; Han S; Liu S; Sun R; Zhao L; Yan C
    ACS Appl Mater Interfaces; 2023 May; 15(21):25339-25353. PubMed ID: 37212295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-shell noble-metal@zeolitic-imidazolate-framework nanocarriers with high cancer treatment efficiency in vitro.
    He L; Pang K; Liu W; Tian Y; Chang L; Liu X; Zhao M; Liu Y; Li Y; Jiang X; Song R; Liu Y
    J Mater Chem B; 2019 Feb; 7(7):1050-1055. PubMed ID: 32254772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting micelles based on folic acid and α-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery.
    Zhang X; Liang N; Gong X; Kawashima Y; Cui F; Sun S
    Colloids Surf B Biointerfaces; 2019 May; 177():11-18. PubMed ID: 30690425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
    Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
    Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
    Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
    Dong K; Zhang Y; Zhang L; Wang Z; Ren J; Qu X
    Talanta; 2019 Mar; 194():703-708. PubMed ID: 30609594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 'dual-key-and-lock' drug carriers for imaging and improved drug release.
    Gao H; Zhang Y; Chi B; Lin C; Tian F; Xu M; Wang Y; Xu Z; Li L; Wang J
    Nanotechnology; 2020 Oct; 31(44):445102. PubMed ID: 32668418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles.
    Yang Y; Long Y; Wang Y; Ren K; Li M; Zhang Z; Xiang B; He Q
    Int J Pharm; 2020 Mar; 577():119085. PubMed ID: 32001290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.